0001921094-23-000405.txt : 20230718 0001921094-23-000405.hdr.sgml : 20230718 20230718161251 ACCESSION NUMBER: 0001921094-23-000405 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230718 DATE AS OF CHANGE: 20230718 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Denali Therapeutics Inc. CENTRAL INDEX KEY: 0001714899 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463872213 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38311 FILM NUMBER: 231094388 BUSINESS ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 866-8548 MAIL ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Schuth Alexander O. CENTRAL INDEX KEY: 0001724311 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O DENALI THERAPEUTICS INC. STREET 2: 151 OYSTER POINT BLVD., 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001724311 XXXXXXXX LIVE 0001714899 Denali Therapeutics Inc. 001-38311 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548 Schuth Alexander O. Officer Common Charles Schwab & Co., Inc.

3000 Schwab Way Westlake TX 76262

9702 291132.00 136888912 07/18/2023 NASDAQ Common 01/03/2023 Restricted Stock Lapse Denali Therapeutics Inc. N 4838 01/03/2023 Equity Compensation Common 01/04/2023 Restricted Stock Lapse Denali Therapeutics Inc. N 4864 01/04/2023 Equity Compensation N ALEXANDER O SCHUTH

161 Oyster Point Blvd. South San Francisco CA 94080

Denali Therapeutics Inc 05/15/2023 10000 286041.00 ALEXANDER O SCHUTH

161 Oyster Point Blvd South San Francisco CA 94080

Denali Therapeutics Inc 07/17/2023 10000 295975.00 07/18/2023 09/30/2022 ALEXANDER O SCHUTH